Enjoy complimentary customisation on priority with our Enterprise License!
The IVF devices and consumables market size is estimated to grow by USD 1.01 billion at a CAGR of 4.5% between 2023 and 2028. The market is experiencing significant growth due to several key factors. The rise in the number of infertility cases worldwide, driven by various factors, including an aging population, unhealthy lifestyles, and environmental factors, is a major growth driver. Another trend influencing market growth is the increasing number of women choosing to delay pregnancies until later in life. However, the high cost of the procedure remains a significant challenge for many potential patients, limiting access to IVF devices and treatment. Despite this, advancements in technology and increasing awareness of infertility issues are expected to drive market growth in the coming years. The market is also witnessing the emergence of new players and innovative solutions, adding to the competitive landscape. Overall, the market is poised for steady growth, driven by demographic trends, technological advancements, and increasing awareness of infertility issues.
The market encompasses a range of products used in Human Fertilisation and Embryology processes. These devices and consumables play a crucial role in the IVF process, including ovulation induction medicines, surgical procedures such as egg retrieval and insemination, fertilization media, and embryo culture and transfer systems. The market is governed by regulatory bodies like the Embryology Authority. The market statistics reflect the growing demand for infertility treatments, with the healthcare sector being a major consumer. The market is expected to grow significantly due to the increasing number of people seeking fertility treatments and advancements in medical technology. The World Hospital initiative aims to revolutionize the conception of global healthcare by setting new standards for medical excellence and accessibility across diverse regions. The process of IVF involves various stages including ovulation, egg retrieval, fertilization, embryo culture, and embryo transfer.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million " for the period 2024-2028, as well as historical data from - for the following segments.
The Culture media and reagents segment is estimated to witness significant growth during the forecast period. The market encompasses a range of instruments, accessories, and disposables used in Human Fertilisation and Embryology (HFE) laboratories for various stages of IVF procedures. These include culture media and reagents, such as buffers, protein-free media, biopsy media, continuous culture media, sperm preparation media, salt solutions, nutrient supplements, protein supplements, amino acids, carbohydrates, and others.
Get a glance at the market share of various regions Download the PDF Sample
The culture media and reagents segment was the largest segment and was valued at USD 1.53 billion in 2018. The growth of this segment is driven by several factors, including the rising incidence of infertility issues among men and women, increasing awareness and focus on Assisted Reproductive Technologies (ART), and the introduction of advanced cultural media and reagents for cell growth and storage at different stages of IVF. Companies like Indira IVF, CCRM Fertility, Cook Medical, and The Cooper Companies Inc. offer a comprehensive range of IVF devices, consumables, and reagents for procedures such as ovulation induction, egg retrieval, insemination, fertilization, embryo culture, embryo transfer, pregnancy, and cryopreservation. In vitro maturation and intracytoplasmic sperm injection are also gaining popularity in the treatment of infertility, delayed pregnancies, and genetic problems. With the increasing number of intended parents and gamete donations, investors are showing significant interest in the development of healthcare infrastructures for IVF procedures.
For more insights on the market share of various regions Download PDF Sample now!
Asia is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In Vitro Fertilization (IVF) is a pioneering Human Fertilisation and Embryology Authority (HFEA) approved technique used to overcome infertility and genetic problems. This advanced reproductive technology involves various procedures such as ovulation induction, egg retrieval, insemination, fertilization, embryo culture, and embryo transfer, culminating in a healthy baby. IVF devices and consumables play a crucial role in this process, including instruments and accessories for surgical procedures, medicines for ovulation induction and fertilization, and disposable items for insemination and embryo transfer. Computer science and genetics have significantly contributed to the development of these technologies, enabling advancements such as Intracytoplasmic Sperm Injection (ICSI) and In vitro maturation (IVM). Cryopreservation of gametes and embryos has further expanded the reach of IVF, addressing delayed pregnancies and facilitating gamete donations for intended parents. The market's growth is driven by the increasing demand for healthcare infrastructure development and the growing number of investors in the sector. Statistics indicate a steady rise in the number of IVF procedures performed worldwide each year, underscoring the importance of continuous innovation in IVF devices and consumables.
The rise in the number of infertility cases is notably driving market growth. Infertility, defined as the inability to conceive after a year of unprotected attempts, affects approximately 6% of married women in the US between the ages of 15 and 49. Additionally, 14% of these women experience impaired fecundity, or difficulty carrying a pregnancy to term. The significant number of couples facing these challenges has led to an increased demand for In Vitro Fertilization (IVF) treatments and related devices and consumables. Furthermore, these essential tools include cryosystems, incubators, imaging systems, ovum aspiration pumps, cabinets, micromanipulators, and various accessories and disposables.
Furthermore, the use of advanced technology, such as artificial intelligence, has expanded the range of IVF applications, leading to improved outcomes. Reagents and media, including cryopreservation media, semen processing media, and ovum processing media, as well as embryo culture media, are integral components of the IVF process. Genetics plays a significant role in the IVF process, with advanced computer science and genetics techniques used to diagnose and address genetic problems. The growing need for these devices and consumables, driven by the increasing prevalence of infertility, is expected to fuel market growth. Thus, such factors are driving the growth of the market during the forecast period.
Emerging trend of delayed pregnancies among women is the key trend in the market. The market is experiencing significant growth due to the increasing number of women delaying childbirth. With age, fertility declines, leading to an increased risk of infertility. This trend is driving the demand for advanced assisted reproductive technology solutions. Technological advancements, including artificial intelligence, are being integrated into various IVF devices such as cryosystems, incubators, imaging systems, ovum aspiration pumps, and micromanipulators.
Furthermore, accessories and disposables, reagents and media, including cryopreservation media, semen processing media, and ovum processing media, are essential components of IVF treatments. The market for these consumables is expected to grow as the number of IVF procedures continues to rise. The use of advanced technology in IVF devices and consumables enhances the chances of successful pregnancies, making them indispensable for fertility clinics and hospitals. Thus, such trends will shape the growth of the market during the forecast period.
The high cost of the procedure is the major challenge that affects the growth of the market. The market encompasses a range of technology-driven products essential for the successful completion of this assisted reproductive technique. These include cryosystems for the preservation and storage of gametes and embryos, incubators for maintaining optimal conditions during embryo culture, imaging systems for monitoring embryo development, ovum aspiration pumps for extracting ova, micromanipulators for handling and manipulating gametes, and various accessories and disposables.
Furthermore, the use of advanced technologies like artificial intelligence and automation is increasingly prevalent in the production of reagents and media, such as cryopreservation media, semen processing media, and ovum processing media, and embryo culture media. Marketing strategies for these products prioritize their ability to streamline the labor-intensive IVF process, improve success rates, and reduce costs for patients. Despite the high cost of IVF procedures, averaging over USD 20,000 per cycle in the US, the market for these devices and consumables continues to grow, driven by the increasing demand for fertility treatments and advancements in technology. Hence, the above factors will impede the growth of the market during the forecast period
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
BIOPSYBELL Srl - The company offers IVF devices and consumables that are indicated for ovum retrieval from the ovaries and reimplantation or cryopreservation.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
In Vitro Fertilization (IVF) is a revolutionary technique in Human Fertilisation and Embryology, overseen by the Embryology Authority. This advanced reproductive technology involves various procedures, including ovulation induction, egg retrieval, insemination, fertilization, embryo culture, and embryo transfer, leading to pregnancy and the birth of a healthy baby. IVF devices and consumables play a crucial role in this process. The market is significant, with a growing demand due to infertility issues, delayed pregnancies, and gamete donations for intended parents.
Furthermore, the market encompasses instruments, accessories, disposables, and medicines used in IVF procedures. IVF procedures address various genetic problems, such as male infertility, and involve surgical procedures like Intracytoplasmic Sperm Injection (ICSI). Healthcare infrastructures are continually developing to accommodate the increasing demand for IVF, with advancements in Computer Science and Genetics influencing the market. Cryopreservation and In vitro maturation are other areas of growth in the IVF market. Statistics indicate that IVF procedures have resulted in over 8 million babies worldwide. The market for IVF devices and consumables is expected to continue growing, providing opportunities for investors.
Market Scope |
|
Report Coverage |
Details |
Page number |
145 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.5% |
Market Growth 2024-2028 |
USD 1.01 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.23 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
Asia at 44% |
Key countries |
US, Germany, India, Spain, and Canada |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
BIOPSYBELL Srl, CCD Laboratory, Cook Group Inc., Esco Medical, FUJIFILM Irvine Scientific Inc., Genea Biomedx, Hamilton Thorne Ltd, Intermedics Ltd., INVO Bioscience Inc., IVFtech ApS, KITAZATO Corp., LabIVF Asia Pte Ltd., Merck KGaA, Progyny Inc, Rocket Medical Plc, SAR Healthline Pvt Ltd., Shivani Scientific Industries Pvt. Ltd., The Cooper Companies Inc., Thermo Fisher Scientific Inc., and Vitrolife AB |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the market forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.